KMT2D and coronary artery disorder: Although individuals with known syndromic disorders were excluded from enrollment in the SVR and ISV trials, we found that 14% of the SV-CHD cohort harbored a damaging genetic variant in a gene known to cause syndromic CHD, including KMT2D, NOTCH1, and ANKRD11 as the most common recurring damaged genes.